0001593968-20-002354.txt : 20201214 0001593968-20-002354.hdr.sgml : 20201214 20201214171031 ACCESSION NUMBER: 0001593968-20-002354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pande Atul CENTRAL INDEX KEY: 0001643071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 201387029 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 1441 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2020-12-14 0001771917 Karuna Therapeutics, Inc. KRTX 0001643071 Pande Atul C/O KARUNA THERAPEUTICS, INC. 33 ARCH ST STE 3110 BOSTON MA 02110-1424 true false false false Common Stock 2020-12-14 4 M false 5714 2.92 A 5714 D Common Stock 2020-12-14 4 S false 5714 92.64 D 0 D Option (right to buy) 2.92 2020-12-14 4 M false 5714 0 D 2016-05-31 2026-05-31 Common Stock 5714 0 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Troy Ignelzi, Attorney-in-Fact 2020-12-14